young biotech company created a new therapeutic class research innovative logo

Gagnant
Contest winning design

Vous souhaitez remporter un projet comme celui-ci ?

Ce client a reçu 7 designs de logo de la part de 4 designers. Il a choisi ce design de logo de alexis alemán comme design gagnant.

Inscrivez-vous Trouvez des Projets de Design

  • terminés - Design Sélectionné
  • Projet Lié 2

Brief de Design de Logo

our logo should be recognizable quickly evoke a therapeutic target, the colors are a mix of blue and sienna (dark orange) the title of the company has pharma but the word must be included in a letter (see example below) H4 ORPHAN PHARMA is a small pharmaceutical company Whose objective is to Develop first in class drugs for the treatment of orphan diseases.H4 ORPHAN PHARMA choose to Develop Idiopathic Pulmonary Fibrosis (IPF). The physiopathology of COPD, severe asthma and IPF are similar. H4 ORPHAN PHARMA chooses to Develop pharmaceutical program on orphan diseases (pulmonary fibrosis and cystic fibrosis) with unmet need. IPF is a disabling and fatal disease Ultimately That affects Approximately 200,000 patients in the USA and Europe, with Approximately 45,000 new cases per year. The median survival time from diagnosis is entre 2 and 5 years, with a 5-years survival rate of Approximately 20%. I want new color (blue or similar with an other color as sienna but i am AGREE with an other color if according with the blue

Marché(s) Cible(s)

GlobalData Expects IPF dirty therapy across USA, France, Germany, Italy, Spain and UK to rise from $ 49m in 2012 to over $ 1.1 trillion by 2017. The EU HAS so far Dominated the GEM market, purpose the US is set to reclaim market share in the future. In 2022, it is planned by various analysts That Esbriet (Marketed since 2012) shoulds Realize a turnover of $ 2 trillion and Slightly less for OVEF (new product on the market). In 2022, the market is expected to be about $ 4 trillion. H4 ORPHAN PHARMA is Positioned as a development company for new pharmaceutical concepts. Its objective is to make the licensing out for ict discoveries in Phase I or Phase II in (clinical proof of concept). H4 ORPHAN PHARMA will Develop CP554 up to Phase I or Phase II And Then make a licensing out with a big pharma company

Coordonnées pour la Carte de Visite

Gaëtan TERRASSE ,MD
CEO
Mob + 33 664 900 654
H4 orphan pharma
20 rue jean Mazen
21 000 DIJON
FRANCE
mail: gaetanterrasse@h4orphan.com
www.h4orphan.com

Texte du logo

H4 ORPHAN PHARMA


Aspect

Chaque curseur illustre les caractéristiques de la marque client et le style que doit transmettre votre design de logo.

Élégant
Audacieux
Léger
Sérieux
Traditionnel
Moderne
Sympathique
Professionnelle
Féminin
Masculin
Coloré
Conservateur
Économique
Haut de gamme

Fichiers
Paiements
1e place
€125
Primes de participation x 3
€50
Total
€275

Date limite du projet
03 avr. 2016 13:07:44 UTC
Options du projet
Projet(s) Lié(s)
Design de Papeterie
Plus d'informations
€24
Design de Carte de Visite
Plus d'informations
€14

Language

Inspiration pour Design de Logo
Bid on my logo design, Cricket club logo design, Mascot logo generator design, Dj logo design, Hindi font logo, Open source logo design, Arabic logo design software, Negative space logo generator, Minimalist logo generator design, Logo auction